MTOR and acute myeloid leukemia: Direct constitutive activation of PI3K/Akt1/mTOR signaling occurs in the majority of leukemias, such as AML and ALL, Hodgkin’s lymphoma, lymphoproliferative disorders or myeloproliferative neoplasms [102,103,104].